Form 4: BlackRock Portfolio Manager Sells Shares

Sentiment:

Insider Transaction Report


A BlackRock Capital Allocation Term Trust portfolio manager sold 5,554 common shares after converting phantom shares.

Worse than expectedA portfolio manager disposed of 5,554.0398 common shares, reducing their direct beneficial ownership in the company.

Summary

  • Russell Jared Koesterich, a Portfolio Manager for BlackRock Capital Allocation Term Trust, reported changes in his beneficial ownership.
  • On January 30, 2026, Koesterich acquired 5,554.0398 shares of common stock through the conversion of phantom shares.
  • Immediately following the acquisition, he disposed of 5,554.0398 shares of common stock at a price of $14.7 per share.
  • This transaction reduced his direct beneficial ownership of common stock to 33,000 shares from a previous holding of 38,554.0398 shares.
  • The phantom shares converted included 3,414.0154 from a January 31, 2025 grant and 2,140.0245 from a January 31, 2024 grant, both vesting in equal installments over three anniversaries.
  • Remaining phantom share holdings are 6,828.0307 from the 2025 grant and 2,140.0245 from the 2024 grant.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative signal, as a portfolio manager reduced their direct equity stake, although the transaction appears to be related to the vesting and immediate sale of equity compensation.

Negatives

  • Portfolio Manager Russell Jared Koesterich disposed of 5,554.0398 common shares at $14.7 each, reducing his direct holdings to 33,000 shares.

Risks

  • The disposition of common stock by a portfolio manager, even if related to equity compensation, could be perceived negatively by the market, potentially impacting investor sentiment.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales by key personnel like portfolio managers, are closely watched by investors for signals regarding management's confidence in the company's future prospects. While this specific transaction appears to be related to the vesting and immediate sale of equity compensation, it still represents a reduction in direct equity exposure by a significant insider.

Stakeholder Impact

  • Shareholders may interpret the portfolio manager's sale of shares as a signal, potentially influencing their perception of the company's short-term prospects.

Key Dates

DateDescription
01/31/2024Grant date for a tranche of phantom shares to the reporting person.
02/02/2024Date of original Form 4 filing reporting phantom shares granted on January 31, 2024.
01/31/2025Grant date for a tranche of phantom shares to the reporting person.
02/04/2025Date of original Form 4 filing reporting phantom shares granted on January 31, 2025.
01/30/2026Date of conversion of phantom shares into common stock and subsequent disposition of common stock.
02/03/2026Signature date of the reporting person's attorney-in-fact for this Form 4 filing.

Recommendation

hold

While the portfolio manager sold shares, the transaction appears to be related to the vesting of equity compensation rather than a discretionary sale based on negative outlook. Investors should monitor future insider activity and company performance, but this single event does not warrant a strong change in investment stance.

Keywords

BlackRock Capital Allocation Term Trust, BCAT, Form 4, Insider Trading, Beneficial Ownership, Portfolio Manager, Stock Sale, Phantom Shares, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.